Introduction to Liver MRI for Surgeons - Diagnosis of Metastatic Liver Cancer -

Introduction to Liver MRI for Surgeons
- Diagnosis of Metastatic Liver Cancer -

Imaging investigations used in liver tumor diagnosis and liver MRI basics (3)

Typical Sequences of liver MRI images9)

Images provided by: Hamamatsu University School of Medicine

T1-weighted images

    Normal liver parenchyma has a homogeneous signal intensity. On T1-weighted images, normal liver parenchyma has a moderate signal intensity (hyperintense compared to skeletal muscle) and is hyperintense compared to the spleen and kidneys. Normal liver parenchyma often has about the same signal intensity as pancreatic parenchyma (Fig. 12, 13).
   On T1-weighted images, subcutaneous tissue and adipose tissue in the abdominal cavity are distinctly hyperintense, creating an easy-to-identify contrast between the contours of the liver and other intraperitoneal organs and the fat that surrounds them. Blood vessels in the liver (portal vein and hepatic veins) are also distinctly hypointense and intrahepatic blood vessels are a useful means of identifying liver segments.  
 

Fig. 12 T1-weighted image (in-phase, TE = 4.17 msec)

Fig. 12 T1-weighted image (in-phase, TE = 4.17 msec)

Fig. 13 T1-weighted image (out-of-phase, TE = 2.08 msec)

Fig. 13 T1-weighted image (out-of-phase, TE = 2.08 msec)

T2-weighted images

    On T2-weighted images, the liver parenchyma has a fairly low but homogeneous signal intensity (Fig. 14, 15). The intrahepatic portal and hepatic veins do not have a fixed intensity but can appear hyperintense or hypointense depending on imaging conditions and the direction and velocity of blood flow. Consequently, caution is required when judging if an image shows normal blood flow or occlusion due to thrombus or tumor embolism.

Fig. 14 Fat-suppressed T2-weighted image

Fig. 14 Fat-suppressed T2-weighted image

Fig. 15 Heavily T2-weighted image (TE = 150 msec)

Fig. 15 Heavily T2-weighted image (TE = 150 msec)

Diffusion-weighted images

    On diffusion-weighted images, normal liver parenchyma has a relatively low signal intensity (Fig. 16) and tumors and other lesions are shown as hyperintense areas within the normal liver parenchyma. Because the diffusion-weighted imaging sequence uses echo planar imaging (EPI), it has a lower spatial resolution than other imaging sequences and is more susceptible to image artifact-induced distortion. For this reason, anatomical structures must be identified by cross-referencing diffusion-weighted images with other images. Some medical facilities may also show diffusion-weighted images with black and white inversed (hyperintense areas in black and hypointense areas in white). When black and white are inversed, caution is required as the relationship between strong and weak signals and black and white structures is reversed. How diffusion-weighted images are displayed is not standardized and is at the discretion of the physician or technologist in the facility. However, the two display methods are easy to distinguish; black and white are reversed when the empty background around the subject is white.

Fig. 16 Diffusion-weighted image (b = 1,000 sec/mm2)

Fig. 16 Diffusion-weighted image (b = 1,000 sec/mm2)

Dynamic contrast enhancement

Fig. 17 Images from each phase of dynamic contrast-enhanced imaging

Fig. 17 Images from each phase of dynamic contrast-enhanced imaging

Detecting metastatic liver cancer with EOB-MRI

EOB-MRI and metastatic liver cancer10,11)

    Most metastatic liver cancers are hypointense to isointense on T1-weighted images. On T2-weighted images, they appear moderately hyperintense (a signal intensity between liver parenchyma and the gallbladder), but caution is also required as metastatic liver cancer can appear strongly hyperintense like the gallbladder in cases with pronounced necrosis or mucinous degeneration. In diffusion-weighted images, metastatic liver cancer often appears markedly hyperintense.
    Hypervascular metastatic liver cancer is normally derived from a primary neuroendocrine tumor, renal cell cancer, melanoma, or thyroid cancer, while hypovascular metastatic liver cancer is normally derived from a primary lung, breast, gastric, or colorectal cancer. Dynamic contrast-enhancement with EOB/Primovist produces different patterns depending on the primary lesion, though metastases from colorectal cancer (a very common cancer) typically appear in the hepatic arterial phase as a hypovascular tumor with ring-shaped enhancement at the periphery of the lesion. In the portal venous phase and transitional phases, metastases demonstrate slight hypointensity compared to the surrounding liver parenchyma with a delayed enhancement in the central portion of the lesion. This enhancement pattern is believed to reflect high tumor cell density and inflammatory response at the periphery of the lesion, and necrosis and degeneration at the central portion of the lesion. Contrast patterns that appear from the hepatobiliary phase obtained in 20 minutes after EOB/Primovist administration reflect the presence or absence of hepatocellular function. Metastatic liver cancer has no hepatocytes and appears hypointense compared to the surrounding liver parenchyma in the hepatobiliary phase, which is helpful in diagnosing metastatic lesions that are undetectable or difficult to differentiate by dynamic contrast-enhancement images alone.

Typical EOB-MRI imaging sequences (Table 3)8)

[Plain MRI]
  • (1)T1-weighted images
    For liver MRI, a breath-hold T1-weighted gradient-echo in- and out-of-phase sequence is essential. Evaluates the interior of the lesion and the fat content of the liver.
  • (2)T2-weighted images
    T2-weighted images are also essential, and a respiratory-triggered fat-suppressed fast spin-echo sequence and breath-hold single-shot fast spin-echo sequence are recommended. Performing additional heavily T2-weighted imaging (TE ≥ 150 msec) is also helpful in distinguishing between the cysts with high T2 values, hemangiomas, and other malignant tumors.
  • (3)Diffusion-weighted images
    An echo-planar diffusion-weighted imaging sequence is also recommended (normally, b-factor ≥ 400 sec/mm2).
  • (4)Other
    Fat-suppressed steady-state coherent images (true FISP, balanced FFE, FIESTA, true SSFP) are recommended.
【EOB-MRI】

    EOB-MRI is used for dynamic and hepatobiliary phase imaging. MRI examination times may be shortened by performing EOB dynamic contrast-enhancement just after non-contrast T1-weighted imaging, followed by acquiring T2-weighted, diffusion-weighted, and steady-stage coherent images before performing hepatobiliary phase imaging (Fig. 18).

Table 3 EOB-MRI protocols (essential)

Imaging method Purpose
Non-contrast-enhanced MRI
Breath-hold T1-weighted image in-phase/out-of-phase
  • Show MRI signals, fat content, and ferrugination in the liver parenchyma, nodules, and tumors before contrast enhancement
  • Verify lipiodol (fatty acid ethyl ester of iodized poppyseed oil) after embolization
Respiration-triggered fat-suppressed T2-weighted image
  • Show MRI signals for indistinct-to-solid nodules and tumors
  • Verify the cysts
Diffusion-weighted image
(either respiratory-triggered or not)
  • Identify the degree of diffusion restriction on water molecules in the liver parenchyma, nodules, and tumors
  • Identify lymph nodes
  • Survey
EOB-MRI
Dynamic contrast-enhancement
(hepatic arterial phase/portal venous phase/transitional phase)
  • Determine the presence of lesions
  • Understand the hemodynamics of nodules and tumors (30, 60 or 90, 120 or 180 seconds after injection)
Fat-suppressed T1-weighted image
(10, 15, 20 minutes)
  • Show the degree of enhancement of liver parenchyma, nodules, and tumors
    (Bi-plane imaging of the hepatobiliary phase after 20 minutes is also recommended)

Fig. 18 A common EOB-MRI examination workflow

Fig. 18 A common EOB-MRI examination workflow

* Called the transitional phase (late phase) in EOB-MRI. The term equilibrium phase is not used in EOB-MRI.